Biden and Sanders Demand Lower GLP-1 Drug Prices from Novo Nordisk and Others

Jul 2, 2024, 02:44 PM

President Joe Biden and Senator Bernie Sanders have co-authored an op-ed calling for pharmaceutical companies to lower the prices of prescription drugs, particularly obesity medications such as Ozempic and Wegovy. This call comes amid rising public concern over the high cost of these drugs, which can reach up to $1,000 per dose despite being producible for just $5. The op-ed highlights the significant financial burden on Americans, who pay some of the highest drug prices in the world. The Biden administration is pressuring companies like Novo Nordisk and Eli Lilly to reduce their prices, with Biden stating that if Big Pharma does not comply, the government will take action to enforce price reductions. This initiative is part of a broader effort to address corporate greed in the pharmaceutical industry and ensure that all Americans have access to affordable medications.